Advertisement

Molecular pathogenesis and clinical immmunology of coeliac disease

  • P. J. Ciclitira
Part of the Immunology and Medicine Series book series (IMME, volume 31)

Abstract

The chapter sets out the definition and history of the description of coeliac disease. It proceeds to describe the epidemiology, pathology, dermatitis herpetiformis, cereal chemistry, toxicity studies, hypothesis for the pathogenesis, genetics, clinical features, physical disorders of bone metabolism, laboratory investigations, diagnosis, disease association, treatment and complications.

Keywords

Bone Mineral Density Coeliac Disease Clinical Immunology Molecular Pathogenesis Dermatitis Herpetiformis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams F. The extant works of Aretaeus the Cappadocian. London Syndenham Society 1856;350.Google Scholar
  2. 2.
    Gee S. On the coeliac affection. St Bartholomew’s Hospital Report 1888;24:17–20.Google Scholar
  3. 3.
    Dicke WK, Weijers NA, Van Der Kamer JH. Coeliac disease. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatria 1953;42:34–42.Google Scholar
  4. 4.
    Greco L, Tozzi AE, Mayer M, Grimaldi M, Silano G, Aurrichio S. Unchanging clinical picture of coeliac disease presentation in Campania, Italy. Euro J Pediatr 1988;148:610–613.Google Scholar
  5. 5.
    Catassi C, Ratsch IM, Fabiani E. et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994;343:200–203.PubMedGoogle Scholar
  6. 6.
    Sheldon W. Prognosis in early adult life of coeliac children treated with a gluten-free diet. Br Med J 1969;2:401–404.PubMedGoogle Scholar
  7. 7.
    Holmes GKT, Prior P, Lane MR, Poke D, Allan RN. Malignancy in coeliac disease - effect of a gluten-free diet. Gut 1989;30:333–338.PubMedGoogle Scholar
  8. 8.
    Isaacson PG. Intestinal lymphoma and enteropathy. J Path 1995; 177:111113.Google Scholar
  9. 9.
    Fry L, Seah PP, Riches DJ, Hoffbrand AV. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lanet 1973;I:288–291.Google Scholar
  10. 10.
    Autran JC, Ellen J, Law L, Nimmo CC, Kasarda DD. N-terminal amino acid sequencing of prolamins of wheat and related species. Nature 1979;282:527529.Google Scholar
  11. 11.
    Frazer AC, Fletcher RF, Ross CAS, Shaw B, Sammons HG, Scheneider R. Gluten-induced enteropathy. The effect of partially digested gluten. Lancet 1959;ii:252–255.Google Scholar
  12. 12.
    Hekkens WThJM, Haex AJ, Willihagen RGJ. Some aspects of gliadin factination and testing by histochemical methods. In: Booth CC, Dowling RH, editors. Coeliac disease. Edinburgh, Churchill Livingstone, 1970:11–19.Google Scholar
  13. 13.
    Howdle PD, Ciclitira PJ, Simpson FG, Losowsky MS. Are all gliadins toxic in coeliac disease? An in vitro study of a, 00DF, y, w-gliadins. Scand J Gastro 1984;19:41–47.Google Scholar
  14. 14.
    Jos J, Charbonnier L, Mosse J, Oliver JP, De Tand MF, Rey J. The toxic fraction of gliadin digests in coeliac disease. Isolation by chromatography in Biogel P10. Clin Chem Acta 1982;199:263–274.Google Scholar
  15. 15.
    Ciclitira PJ, Evans DJ, Fagg NLK, Lennox ES, Dowling RH. Clinical testing of gliadin fractions in coeliac patients. Clinical Science 1984;66:357–364.PubMedGoogle Scholar
  16. 16.
    Kagnoff MF, Raleigh KA, Hubert JJ, Bernardin JE, Kasarda DD. Possible role for a human adenovirus in the pathogenesis of coeliac disease. J Exp Med 1984;160:1544–1557.PubMedGoogle Scholar
  17. 17.
    Kagnoff MF, Paterson NY, Kumar PJ, et al. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987;28:995–1001.PubMedGoogle Scholar
  18. 18.
    Molberg O, McAdam SN, Korner R et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognised by gut-derived T-cells in coeliac disease. Nature Medicine 1998;4:713–717.PubMedGoogle Scholar
  19. 19.
    Gjertsen HA, Lundin KEA, Sollid LM, Eriksen JA, Thorsby E. A T-cell clone recognising a peptide derived from a-gliadin when presented by the coeliac disease associated HLA-DQ (A1*0501, BI*0201) molecule, Scand J Immunol 1994;39:567–574.PubMedGoogle Scholar
  20. 20.
    Lundin KEA, Scott H, Hansen T, et al. Gliadin specific, HLA-DQ (al*0501, 00DFl*0201) restricted T-cells isolated from the small intastinal mucosa of coeliac disease patients. J Exp Med 1993; 178: 187–196.PubMedGoogle Scholar
  21. 21.
    Wiser H, Belitz H-D, Ashkenazi A, Idar D. Isolation of coeliac-active peptide fractions from gliadin. Z Lebensm Unter Forsch 1983;176:85–94.Google Scholar
  22. 22.
    Wiser H, Belitz H-D, Ashekenazi A. Amino acid sequence of the coeliac active peptide B3142. Z Lebensm Unter Forsch 1984;179:371–376.Google Scholar
  23. 23.
    Sturgess RP, Day P, Ellis HJ, et al. Wheat peptide challenge in coeliac disease. Lancet 1994;343:758–761.PubMedGoogle Scholar
  24. 24.
    Kontakou M, Przemioslo RT, Sturgess RP, et al. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut 1995;37:52–57.PubMedGoogle Scholar
  25. 25.
    Shidrawi RG, Rosen-Bronson S, Wagner A, Ciclitira PJ. Binding of gluten peptides to HLA-class II transfectants in coeliac disease. Gut 1996;38:A32.Google Scholar
  26. 26.
    Johansen BH, Gjertsen HA, Vartdal F, et al. Binding of peptides from the N-terminal region of a-gliadin to the coeliac-associated HLA-DQ2 molecule assessed in biochemical and T-cell assays. Clin Immunol and Immunopathol 1996;79:288–293.Google Scholar
  27. 27.
    Bailey AS, Freedman AR, Price B, Chescoe D, Ciclitira PJ. Early biochemical responses of coeliac small intestine to wheat gliadin. Gut 1989;30:78–85.PubMedGoogle Scholar
  28. 28.
    Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AVS. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nature Medicine 2000;6:337–42.PubMedGoogle Scholar
  29. 29.
    Arentz-Hansen H, Korner R, Molberg O, et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191:603–12.PubMedGoogle Scholar
  30. 30.
    Peters TJ, Bjarnason I. Coeliac syndrome: biochemical mechanisms and the missing peptidase hypothesis revisited. Gut 1984;25:913–918.PubMedGoogle Scholar
  31. 31.
    Zimmer KP, Naim H, Weber P, Ellis HJ, Ciclitira PJ. Targeting of gliadin peptides, CD8, a/ß and y/S-TCR to Golgi complexes and vacuoles within coeliac disease enterocytes. FASEB Journal 1998;12:1349–1357.PubMedGoogle Scholar
  32. 32.
    Weiser MM, Douglas AP. An alternative mechanism for gluten toxicity in coeliac disease. Lancet 1976;I:567–569.Google Scholar
  33. 33.
    Douglas A. The binding of a glycopeptide component of wheat gluten to intestinal mucosa of normal and coeliac human subjects. Clin Chem 1976;73:357–361.Google Scholar
  34. 34.
    Colyer J, Farthing MJG, Kumar PJ, Clark ML, Ohannesian AD, Waldron NM. Reappraisal of the “lectin hypothesis” in the aetio-pathogenesis of coeliac disease. Clin Sci 1985;71:105–110.Google Scholar
  35. 35.
    Marsh MN. Immunocytes, enterocytes and the lamina propria: an immunopathological framework of coeliac disease. J Roy Coll Phys Lon 1983;17:205–212.Google Scholar
  36. 36.
    Blumgart Hl. Three fatal cases of malabsoption of fat with emaciation and anaemia and in two acidosis and tetany. Arch Intern Med 1923;32:113–128.Google Scholar
  37. 37.
    Yiannakou Jy, Dell’Olio D, Saaka M. Detection and characterisation of antiendomysial antibody in coeliac disease using human umbilical cord. Int Arch All Immunol 1997;112:140–144.Google Scholar
  38. 38.
    Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of coeliac disease. Nature Medicine 1997;3:797–801.PubMedGoogle Scholar
  39. 39.
    Kontakou M, Sturgess RP, Przemioslo RT, Limb GA, Nelufer JM, Ciclitira PJ. Detection of interferon-y mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut 1994;35:1037–1041.PubMedGoogle Scholar
  40. 40.
    Przemioslo RT, Lundi KEA, Sollid LM, Nelufer JM, Ciclitira PJ. Histological changes in small bowel mucosa induced by gliadin sensitive-Tlymphocytes can be blocked by anti-interferon-y antibody. Gut 1995;36:874879.Google Scholar
  41. 41.
    Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of coeliac disease to a particular HLA-DQ a/13 heterodimer. J Exp Med 1989;169:345–350.PubMedGoogle Scholar
  42. 42.
    Hall MA, Lanchbury JSS, Bolsover WJ, Welsh MI, Ciclitira PJ. Coeliac disease is associated with an extended HLA-DR3 haplotype which includes HLA-DPw I. Hum Immunol 1990;27:220–228.PubMedGoogle Scholar
  43. 43.
    Herrera M, Chertkoff L, Palavecino E. Restriction fragment length polymorphism in HLA-class II genes of Latin American caucasian coeliac disease patients. Hum Immunol 1989;26:272–280.PubMedGoogle Scholar
  44. 44.
    Tighe MR, Hall MA, Ashkenazi A, Siegler E, Lanchbury JSS, Ciclitira PJ. Coeliac disease among Ashkenazi Jews from Israel: a study of the HLA-class II alleles and their assosiation with disease susceptibility. Hum Immunol 1993;38:270–276.PubMedGoogle Scholar
  45. 45.
    Zhong F, McCombs CC, Olson JM, Elston RC, Stevens FM, McCarthy CF. An autosomal screen for genes that predispose to coeliac disease in the western counties of Ireland. Nat Gen 1996;14:229–333.Google Scholar
  46. 46.
    Greco L, Corazza G, Babron M-C, et al. Genome search in coeliac disease. Am J Hum Gen 1998;62:669.Google Scholar
  47. 47.
    Yiannakou JY, Brett PM, Morris M-A, et al. Family linkage study of the T-cell receptor genes in coeliac disease. Italian J Gastroenterol Hepatol 1999;31:198–201.Google Scholar
  48. 48.
    Damen GM, Boersma B, Wit JM, Heymans HS, Catch-up growth in 60 children with coeliac disease. J Pediatr Gastro Nutr 1994;19:394–400.Google Scholar
  49. 49.
    Molteni N, Badella M, Bianchi P. Obstetric and gynaecological problems in women with untreated coeliac sprue. J Clin Gastroenterol 1990;12:337.Google Scholar
  50. 50.
    Cooke WT, Holems GKT. Clinical presentation. In: Cooke WT, Holmes GKT, editors. Coeliac disease. London, Churchill Livingston, 1984:90–95.Google Scholar
  51. 51.
    Aine L, Maki M, Collin P, Keyrilainen O. Dental enamel defects in coeliac disease. J Oral Pathol Med 1990;19:271.Google Scholar
  52. 52.
    Collin P, Vilska s, Heinonen PK, Hallstrom O, Pikkarainen P. Infertility and coeliac disease. Gut 1996;39:382–384.Google Scholar
  53. 53.
    Jones B, Bayless TM, Fishman EK, Siegelman SS. Lymphodenopathy in celiac disease: computed tomographic observations. Am J Roent-genology 1984;142:1127–1132.Google Scholar
  54. 54.
    Corazza GR, Amorosa L, Strocchi A, et al. Assesmant of prevalence, familial occurance, and possible factors inducing splenic hypofunction in adult coeliac disease in Italy. Gut 1989;30:A1452–53.Google Scholar
  55. 55.
    O’Grady JG, Stevens FM, Harding B, et al. Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastroenterology 1984;87:1325–1331.Google Scholar
  56. 56.
    Ferguson A, Hutton MM, Maxwell JD, Muray D. Adult coeliac disease in hyposplenic patients. Lancet 1970;i:163–64.Google Scholar
  57. 57.
    Corazza GR, Frisoni M, Vaira D, Gasbarrini G. Effect of guten-free diet on splenic hypofunction of adult coeliac disease. Gut 1983;24:228–230PubMedGoogle Scholar
  58. 58.
    Corazza GR, Biagi F, Volta U, et al. Non-malignant complications of coeliac disease. In: Maki M, Collin P, Visakorpi JK, editors. Coeliac disease. Tampere, Coeliac Study Group, 1997:95–96.Google Scholar
  59. 59.
    Bennet TI, Hunter D, Vaughan JM. Idiopathic steatorrhoea (Gee’s disease) a nutritional disturbance associated with tetany osteomalacra and anaemia. QJM 1932;i:603–677.Google Scholar
  60. 60.
    Trier JS. Celiac sprue. New Eng Med 1991;325:1709–1719.Google Scholar
  61. 61.
    Cora GR, Di Sario A, Ceccheti L, Tarozzi C, et al. Bone mass and metabolism in patients with coeliac disease. Gastroenterology 1995;109:122128.Google Scholar
  62. 62.
    Walters JR, Banks LM, Butcher GH, Fowler CR. Detection of low bone mineral density by dual energy x-ray absorptiometry in unsuspected suboptimally treated coeliac disease. Gut 1995;37:220–224.PubMedGoogle Scholar
  63. 63.
    Pistorius LR. Sweidan WH. Purdie DW, et al. Coeliac disease and bone mineral density in adult female patients. Gut 1995;37:639–642.PubMedGoogle Scholar
  64. 64.
    Walters JRF. Bone mineral density in coeliac disease. Gut 1994;35:150–151.PubMedGoogle Scholar
  65. 65.
    McFarlane XA, Bhalla AK, Reeves DE, Morgan LM, Robertson DA. Osteoporosis in treated adult coeliac disease. Gut 1995;36:710–714.PubMedGoogle Scholar
  66. 66.
    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Resa 1994; 9:1137–1141.Google Scholar
  67. 67.
    Lindh E, Ljunghall S, Larsson K, Lavo B. Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med 1992;231:403–406.PubMedGoogle Scholar
  68. 68.
    Molteni N, Caraceni MP, Badella MT, Ortolani S, Gandolini GG, Bianchi P. Bone mineral density in adult coeliac patients and the effect of gluten-free diet from childhood. Am J Gastroenterol 1990;85:51–53.PubMedGoogle Scholar
  69. 69.
    Caraceni MP, Molteni N, Bardella MT, Ortolani S, Nogara A, Bianchi PA. Bone and mineral metabolism in adult coeliac disease. Am J Gstroenterol 1988;83:274–277.Google Scholar
  70. 70.
    Valdimarsson T, Lofman O, Toss G, Strom M. Reversal of osteopenia with diet in adult coeliac disease. Gut 1996;38:322–327.PubMedGoogle Scholar
  71. 71.
    McFarlane XA, Bhalla AK, Robertson DAF. Effect of a gluten-free diet on osteopenia in adults with newly diagnosed coeliac disease. Gut 1996;39:180184.Google Scholar
  72. 72.
    Mautalen C, Gonzalez D, Mazure R, et al. Effect of treatment on bone mass, mineral metabolism, and body composition in untreated coeliac disease patients. Am J Gastroenterol 1997;92:313–318.PubMedGoogle Scholar
  73. 73.
    Bai JC, Gonzalez D, Mautalen C, et al. Long-term effect of gluten restriction on bone mineral density of patients with coeliac disease. Aliment Pharmacol Ther 1997;11:157–164.PubMedGoogle Scholar
  74. 74.
    Valdimarsson T, Toss G, Ross I, Lofman O, Strom M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994;29:457–461.PubMedGoogle Scholar
  75. 75.
    Mora S, Barera G, Ricotti A, Weber G, Bianchi C, Chiumello G. Reversal of low bone density with a gluten-free diet in children and adolescents with coeliac disease. Am J Clin Nutr 1998;67:477–481.PubMedGoogle Scholar
  76. 76.
    Marsh MM. Bone disease and gluten-sensitivity: time to act, to treat, and to prevent. Am J Gastroenterol 1994;89:2105–2107.PubMedGoogle Scholar
  77. 77.
    Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis. N Engl J Med 1992; 327:620–627.PubMedGoogle Scholar
  78. 78.
    Eastell T. Treatment of postmenopausal osteoporosis. N Engl J Med 1998;338:736–746.PubMedGoogle Scholar
  79. 79.
    Ciclitira PJ, Ellis HI, Evans DJ. A solid-phrase radioimmunoassay for measurement of circulating antibody titres to wheat gliadin and its subfractions in patients with adult coeliac disease. J Immunol Meth 1983;62:231–239.Google Scholar
  80. 80.
    Sategna-Guidetti C, Grosso SB, Bruno M, Grosso S. Is human umbilical cord the most suitable substrate for the detection of endomysium antibodies in the screening and follow-up of coeliac disease? Euro J Gastroenterol Hepatol 1997;9:657–60.Google Scholar
  81. 81.
    Feighery C, Whelan A, Weir DG. Endomysium: autoantigen in coeliac disease. Euro J Gastroenternol Hepatol 1997;9:655–6.Google Scholar
  82. 82.
    Burgin-Wolff A, Gaze H, Hadziselimovic F, Huber H, et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991;66:941–947.PubMedGoogle Scholar
  83. 83.
    Stahlberg MR, Savilahti E, Siimes MA. Iron deficiency in coeliac disease is mild and is detected and corrected by gluten-free diet. Acta Paediatr Scand 1991;80:190–3.PubMedGoogle Scholar
  84. 84.
    Depla Ac, Bartelsman GH, Mulder CI Tytgat GN. Anaemia: monosymptomatic coeliac disease a report of 3 cases. Hepatogastroenterology 1990;37:90.Google Scholar
  85. 85.
    Benson GD, Kowlessar OB, Sleisenger MH. Adult coeliac disease with emphasis upon resistance to the gluten-free diet. Medicine 1964;43:1–40.PubMedGoogle Scholar
  86. 86.
    Trowell HC. Dimorphic anaemia and deficiency of iron associated with nutritional macrocytic anaemia. Trans R Soc Trop Med Hyg 1943;37:19–40.Google Scholar
  87. 87.
    Nelson EW, Ertran A, Brooks AP, Creda JJ, Thrombocytosis in patients with coeliac sprue. Gastroenterology 1976;70:1042–4.PubMedGoogle Scholar
  88. 88.
    O’Grady JG, Stevens FM, Harding B, et al. Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence and relationship to diet and small bowel morphology. Gastroenterology 1984;87:1326–1331.PubMedGoogle Scholar
  89. 89.
    Porter KG, McMaster D, Elmes ME, Love AHG. Anaemia and low serum copper during zinc therapy. Lancet I977;ii:774.Google Scholar
  90. 90.
    Ciclitira, P J, Harkiss, G D, Hunter, J O. The incidence of immune complexes by the Polyethylene Glycol Precipitation Complement Test (PEG-CC) in coeliac disease and inflammatory bowel disease. Gut 1979;20:A909.Google Scholar
  91. 91.
    Stewart JS, Pollock DJ, Hoffbrand AV, Mollin DL, Booth CC, A study of proximal and distal intestinal structure and absorptive function in idiopathic steatorrhoea. QJM 1967;36:425–444.PubMedGoogle Scholar
  92. 92.
    Menzies IS, Laker M, Pounder R, et al. Abnormal intestinal permeability to sugar in villous atrophy. Lancet 1984;ii:1107–1109.Google Scholar
  93. 93.
    Low-Bear TS, Heaton KW, Heaton ST, Read AE. Gall bladder inertia and sluggish enterohepatic ciculation of bile-salts in coeliac disease. Lancet 1971;I:991–994.Google Scholar
  94. 94.
    Picarrelli A, Maiuri L, Mazzilli MC, et al. Gluten-sensitive disease with mild enteropathy. Gastroenterology 1996;111:608–16.Google Scholar
  95. 95.
    Marsh MN. Gluten sensitivity and latency: can patterns of intestinal antibody secretion define the great silent majority? Gastroenterology 1993;104:15503.Google Scholar
  96. 96.
    Brocchi E, Corazza Gr, Caletti G, Treggiari EA, Barbara L, Gasbarrini G. Endoscopie demonstration of loss of duodenal folds in the diagnosis of coeliac disease. N Eng J Med 1988;319:741–744.Google Scholar
  97. 97.
    Shidrawi RG, Przemioslo R, Davies DR, Tighe MR, Ciclitira PJ. Pitfalls in diagnosing coeliac disease. J Clin Path 1994;47:693–694.PubMedGoogle Scholar
  98. 98.
    Cooke WT, Holmes GKT. Coeliac disease definition and epidemiology. In: Cooke WT, Holmes GKT, editors. Coeliac disease. London, Churchill Livingstone. 1983:p2–22.Google Scholar
  99. 99.
    Rubin CF, Brandborg LL, Flick AL, et al. Biopsy studies on the pathogenesis of coeliac sprue. In: Wolstenholme GEW, Cameron MP, editors. Intestinal Biopsy. London, Ciba Foundation Study Group 14, 1962:67–83.Google Scholar
  100. 100.
    Marsh MN, Brown AC, Swift JA. The Ultra-structure of the small intestinal mucosa of normal control human subjects and of patients with untreated and treated coeliac disease using the scanning electron microscope. In: Booth CC, dowling RH, editors. Edinburgh, Churchill Livingstone, 1979:26–44.Google Scholar
  101. 101.
    Scott BB, Losowsky MS. Coeliac disease: a cause of various associated diseases. Lancet 1975;ii:956.Google Scholar
  102. 102.
    Maki M, Hallstrom O, Huupoonen T, Vesikari T, Visakorpi JK. Increased prevalence of coeliac disease in diabetes. Arch Dis Child 1984;59:739–42.PubMedGoogle Scholar
  103. 103.
    Cacciari E, Salardi S, Volta U, et al. Prevalence and characteristics of coeliac disease in type 1 diabetes mellitus. Acta Paediatr Scand 1987;76:671–2.PubMedGoogle Scholar
  104. 104.
    Savilahti E, Simell O, Koskimies S, Rilva A, Akerblom HK. Coeliac disease in insulin-dependant diabetes mellitus. J Pediat 1986;108:690–692.PubMedGoogle Scholar
  105. 105.
    Collin P, Salmi J, Hallstrom O, et al. High frequency of coeliac disease in adult patients with type 1 diabetes. Scand J Gastroenterol 1989;24:81.PubMedGoogle Scholar
  106. 106.
    Hay JE, Wiesner RH, Sherter RG, La Russo NF, Baldus WP. Primary sclerosing cholangitis and coeliac disease. A novel association. Ann Int Med 1988;109:713–7.PubMedGoogle Scholar
  107. 107.
    Behr W, Barnett J. Adult coeliac disease and primary biliary cirrhosis. Am J Gastroenterol 1986;81:796–9.Google Scholar
  108. 108.
    Ginn P, Workman RD. Primary biliary cirrhosis and adult coeliac disease. West J Med 1992;156:547–9.Google Scholar
  109. 109.
    Lancaster-Smith MJ, Benson MK, Strickland ID. Coeliac disease and diffuse intestinal lung disease. Lancet 1971;I:473–476.Google Scholar
  110. 110.
    Edwards C, Williams A, Asquith P. Bronchopulmonary disease in coeliac disease. J Clin Path 1985;38:361–7.PubMedGoogle Scholar
  111. 111.
    Curtis WD, Schuman BM, Griffin JW Jr. Association of gluten-sensitive enteropathy and Crohn’s colitis. Am J Gastroenterol 1992;87:1634–7.PubMedGoogle Scholar
  112. 112.
    Kitis G, Holmes GKT, Cooper BT, Thompson H, Allan RN. Assosiation of coeliac disease and inflammatory bowel disease. Gut 1980;21:636–41.PubMedGoogle Scholar
  113. 113.
    Breen EGG, Coghlan G, Connoly EC. Increased association of ulcerative colitis and coeliac disease. Ir J Med Sci 1987;156:120–1.PubMedGoogle Scholar
  114. 114.
    Shah A, Mayberry JF, Williams G, et al. Epidermological survey of coeliac disease and inflammatory bowel disease in first-degree relatives of coeliac patients. Q J Med 1990;74:283–8.PubMedGoogle Scholar
  115. 115.
    Loft DE, Marsh MN, Sandle GI, et al. Studies of intestinal lymphoid tissue XII. Epithelial lymphocyte and mucosal responses to rectal gluten challenge in coeliac sprue. Gastroenterology 1989;97:29–37.PubMedGoogle Scholar
  116. 116.
    Loft DE, Marsh MN, Crowe PT. Rectal gluten challenge and diagnosis of coeliac disease. Lancet 1990;335:1293–1295.PubMedGoogle Scholar
  117. 117.
    Armes J. Gee DC, Macrae FA, Schroeder W, Bhathal PS. Collagenous colitis: jejunal and colorectal pathology. J Clin Path 1992;45:784–787.PubMedGoogle Scholar
  118. 118.
    Bayless TM, Kaplowitz RF, Shelley WM, Ballinger WR, Hendrik TR. Intestinal ulceration a complication of coeliac disease. New Eng J Med 1967;776:996–1002.Google Scholar
  119. 119.
    Howell MD, Smith JR, Austin RK, et al. An extended F1LA-D region haplotype associated with coeliac disease. Proc Nat Acad Sci USA 1988;85:222–226.PubMedGoogle Scholar
  120. 120.
    Isaacson PG, O’Connor NTJ, Spencer JO, et al. Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet 1985;ii:616–621.Google Scholar
  121. 121.
    Loberant N, Cohenb I, Noi I, Herskovits M, Szvalb S. Enteropathyassociated T-cell lymphoma: a case report with radiographic and computed tomography appearance. J Surg Oncol 1997;65:50–54.PubMedGoogle Scholar
  122. 122.
    McClelland HA, Lewis MJ, Naish JM. Idiopathic steatorrhoea with intestinal pseudo-obstruction. Gut 1962;3:142–145.PubMedGoogle Scholar
  123. 123.
    McNeish AS, Rolles CJ, Arthur LJ. Criteria for diagnosis of temporary gluten intolerance. Arch Dis Child 1976;52:275–278.Google Scholar
  124. 124.
    Cooper BT, Holmes GK, Ferguson R, Thompson RA, Allan RN, Cooke WT. Gluten-sensitive diarrhoea without evidence of coeliac disease. Gastroenterology 1980;79:801–6.PubMedGoogle Scholar
  125. 125.
    Esko K, Janatuinen MD, Pekka H, et al. A comparison of diets with and without oats in adults with coeliac disease. N Engl J Med 1995;33:10331037.Google Scholar
  126. 126.
    Pink IJ, Creamer B. Response to a gluten-free diet of patients with coeliac syndrome. Lancet 1967;i:300–304.Google Scholar
  127. 127.
    Von Krainick HG, Debantin F, Gautier E, Tobler R, Velasco JA. Additional research of the injurious effect of wheat flour in Coelic disease. Acute gliadin reactions (gliadin shock). HeIv Paediatr Acta 1958;13:432–454.Google Scholar
  128. 128.
    Hamilton JR, Chamders RA, Wynn-Williams A. Role of gluten, prednisone and azathioprine in non-responsive coeliac disease. Lancet 1976;21:1213–16.Google Scholar
  129. 129.
    Duerksen DR, Ma MM, Jewell LD. Failure of immunosuppresive therapy to prevent relapse of coeliac sprue. J Clin Gastro 1995;21:255–257.Google Scholar
  130. 130.
    Longstreth GFF. Successful treatmant of refractory sprue with cyclosporine. Ann Int Med 1993; 119:1014–6.PubMedGoogle Scholar
  131. 131.
    Pallis CA, Lewis PD. Neurological complications of coeliac disease and tropical sprue. In: The Neurology of Gastrointestinal Disease. London, WB Saunders, 1994:138–156.Google Scholar
  132. 132.
    Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease. Brain 1966;89:683–722.PubMedGoogle Scholar
  133. 133.
    Kinney HC, Berger PC, Hurwitz BJ, Hijmans JC, Grant JP. Degeneration of the central nervous system associated with coeliac disease. J Neurol Sci 1982;53:9–22.PubMedGoogle Scholar
  134. 134.
    Kristoferitsch W, Pointer H. Progressive cerebellar syndrome in adult coeliac disease. J Neurol 1987;234:116–8.PubMedGoogle Scholar
  135. 135.
    Kaplan JG, Pack D, Horoupian D, DeSouza T, Brin M, Schaumburg H. Distal axonopathy associated with chronic gluten enteropathy; a treatable disorder. Neurology 1988;38:642–5.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • P. J. Ciclitira

There are no affiliations available

Personalised recommendations